Melicent C. Peck

2.3k total citations
15 papers, 433 citations indexed

About

Melicent C. Peck is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Melicent C. Peck has authored 15 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Melicent C. Peck's work include Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Legume Nitrogen Fixing Symbiosis (4 papers). Melicent C. Peck is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Legume Nitrogen Fixing Symbiosis (4 papers). Melicent C. Peck collaborates with scholars based in United States, Canada and Spain. Melicent C. Peck's co-authors include Sharon R. Long, Robert F. Fisher, Montserrat Carrasco‐Triguero, Kuo‐Chen Yeh, Rong Deng, Jorge A. Tavel, Ola M. Saad, Nicholas Lewin‐Koh, Carrie M. Rosenberger and Amrita V. Kamath and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Bacteriology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Melicent C. Peck

15 papers receiving 420 citations

Peers

Countries citing papers authored by Melicent C. Peck

Since Specialization

Citations

This map shows the geographic impact of Melicent C. Peck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melicent C. Peck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melicent C. Peck more than expected).

Fields of papers citing papers by Melicent C. Peck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melicent C. Peck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melicent C. Peck. The network helps show where Melicent C. Peck may publish in the future.

Co-authorship network of co-authors of Melicent C. Peck

This figure shows the co-authorship network connecting the top 25 collaborators of Melicent C. Peck. A scholar is included among the top collaborators of Melicent C. Peck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melicent C. Peck. Melicent C. Peck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial* 2022 ·Critical Care Medicine ·Michael R. Waters, James A. McKinnell, André C. Kalil, Greg S. Martin, Timothy G. Buchman, (unknown), Xiaoying Yang, Annemarie Lekkerkerker, Tracy Staton, Carrie M. Rosenberger, Rajita Pappu, Yehong Wang, Wenhui Zhang, Logan Brooks, Dorothy Cheung, Joshua Galanter, Hubert Chen, (unknown), Melicent C. Peck, (unknown)	14
2	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Monoclonal Antibody MHAA4549A in Patients With Acute Uncomplicated Influenza A Infection 2021 ·Open Forum Infectious Diseases ·Jeremy J. Lim, (unknown), (unknown), Juan Pablo Horcajada, (unknown), Allen Nguyen, Jacqueline McBride, Rong Deng, Joshua Galanter, Tom Chu, Elizabeth M. Newton, Jorge A. Tavel, Melicent C. Peck	10
3	167. A Phase 1b, Randomized, Double-blind, Placebo-controlled, Multiple-ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Patients with staphylococcus Aureus Bacteremia Receiving Standard-of-care Antibiotics 2020 ·Open Forum Infectious Diseases ·Jeremy J. Lim, Nicholas Lewin‐Koh, Tom Chu, (unknown), Aklile Berhanu, Montserrat Carrasco‐Triguero, (unknown), Wouter L. W. Hazenbos, Loren G. Miller, Vance G. Fowler, José M. Miró, Jessica A. Couch, Melicent C. Peck	6
4	1305. Comparison of Pharmacokinetics of DSTA4637S, a novel THIOMABTM Antibody-Antibiotic Conjugate, in Patients with Staphylococcus aureus Bacteremia Receiving Standard-of-Care Antibiotics with Pharmacokinetics in Healthy Volunteers 2020 ·Open Forum Infectious Diseases ·(unknown), Rong Deng, Ryan Owen, Ola M. Saad, Aklile Berhanu, Jeremy J. Lim, Montserrat Carrasco‐Triguero, Jessica A. Couch, Melicent C. Peck	5
5	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of MHAA4549A, a Monoclonal Antibody, plus Oseltamivir in Patients Hospitalized with Severe Influenza A Virus Infection 2020 ·Antimicrobial Agents and Chemotherapy ·Jeremy J. Lim, Anna Nilsson, Michael Silverman, Nimer Assy, (unknown), Jacqueline McBride, Rong Deng, (unknown), Xiaoying Yang, Allen Nguyen, (unknown), Mauricio Maia, (unknown), Melicent C. Peck, Joshua Galanter, Tom Chu, Elizabeth M. Newton, Jorge A. Tavel	29
6	Risk stratification biomarkers for Staphylococcus aureus bacteraemia 2020 ·Clinical & Translational Immunology ·Yi Cao, (unknown), Melicent C. Peck, Oleg Mayba, Felicia Ruffin, Kyu Hong, Montserrat Carrasco‐Triguero, Vance G. Fowler, Stacey A. Maskarinec, Carrie M. Rosenberger	9
7	Pharmacokinetics of the Monoclonal Antibody MHAA4549A Administered in Combination With Oseltamivir in Patients Hospitalized With Severe Influenza A Infection 2020 ·The Journal of Clinical Pharmacology ·Rong Deng, (unknown), Mauricio Maia, Jeremy J. Lim, Melicent C. Peck, Jacqueline McBride, (unknown), (unknown), (unknown), Elizabeth M. Newton, Jorge A. Tavel, William D. Hanley	7
8	A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti- Staphylococcus aureus Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers 2019 ·Antimicrobial Agents and Chemotherapy ·Melicent C. Peck, Michael E. Rothenberg, Rong Deng, Nicholas Lewin‐Koh, (unknown), Amrita V. Kamath, Montserrat Carrasco‐Triguero, Ola M. Saad, (unknown), (unknown), (unknown), (unknown), Jorge A. Tavel	79
9	Prognostic Power of Pathogen Cell-Free DNA in Staphylococcus aureus Bacteremia 2019 ·Open Forum Infectious Diseases ·(unknown), Johnny Gutierrez, Stacey A. Maskarinec, Yi Cao, Kyu Hong, Felicia Ruffin, Montserrat Carrasco‐Triguero, Melicent C. Peck, Vance G. Fowler, Amos Baruch, Carrie M. Rosenberger	12
10	Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated Staphylococcus aureus Bacteremia 2019 ·Open Forum Infectious Diseases ·Johnny Gutierrez, (unknown), Nicholas Lewin‐Koh, Aklile Berhanu, Min Xu, Yi Cao, Janice Kim, Donghong Yan, (unknown), Jason B. Dinoso, Catherine A. Koss, Angelo Clemenzi-Allen, Henry F. Chambers, Melicent C. Peck, Amos Baruch, Carrie M. Rosenberger	11
11	A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection 2018 ·Clinical Infectious Diseases ·(unknown), Yi Cao, Kyu Hong, Oleg Mayba, Melicent C. Peck, Johnny Gutierrez, Felicia Ruffin, Montserrat Carrasco‐Triguero, Jason B. Dinoso, Angelo Clemenzi-Allen, Catherine A. Koss, Stacey A. Maskarinec, Henry F. Chambers, Vance G. Fowler, Amos Baruch, Carrie M. Rosenberger	41
12	Isolation and Characterization of Mutant Sinorhizobium meliloti NodD1 Proteins with Altered Responses to Luteolin 2013 ·Journal of Bacteriology ·Melicent C. Peck, Robert F. Fisher, (unknown), Sharon R. Long	22
13	Diverse Flavonoids Stimulate NodD1 Binding tonodGene Promoters inSinorhizobium meliloti 2006 ·Journal of Bacteriology ·Melicent C. Peck, Robert F. Fisher, Sharon R. Long	147
14	Luteolin and GroESL Modulate In Vitro Activity of NodD 2002 ·Journal of Bacteriology ·Kuo‐Chen Yeh, Melicent C. Peck, Sharon R. Long	32
15	The RNA Polymerase α Subunit from Sinorhizobium meliloti Can Assemble with RNA Polymerase Subunits from Escherichia coli and Function in Basal and Activated Transcription both In Vivo and In Vitro 2002 ·Journal of Bacteriology ·Melicent C. Peck, Tamás Gaál, Robert F. Fisher, Richard L. Gourse, Sharon R. Long	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact